12/16/2021 / By Ethan Huff
The “science” behind the so-called “vaccines” for the Tony Fauci Virus (Covid-19) is apparently now so solid that federal regulatory bodies no longer feel that they need to consult their advisory committees before authorizing the jabs for younger age groups.
The latest victims are 16- and 17-year-olds, which reportedly can now get injected with mRNA shots from Pfizer and BioNTech. This decision was made by the U.S. Food and Drug Administration (FDA) without consultation from its Vaccines and Related Biological Products Advisory Committee (VRBPAC).
The VRBPAC is an independent body of vaccine advisors that back on December 9 announced in a press release that the FDA purposely did not meet with it before granting this latest authorization.
“[The] agency previously convened the committee for extensive discussions regarding the use of booster doses of COVID-19 vaccines and, after review of Pfizer’s EUA [emergency use authorization] request, the FDA concluded that the request does not raise questions that would benefit from additional discussion by committee members,” the announcement explained.
According to Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, the Pfizer-BioNTech injection has had emergency use authorization (EUA) since December 2020 when Donald Trump was still president. He claims that immunity from the jab “is waning” in adults and children aged 16-17.
A “single booster dose of the vaccine for those vaccinated at least six months prior will help provide continued protection against COVID-19 in this and older age groups,” Marks maintains.
It turns out that the most at-risk demographic for myocarditis and pericarditis post-injection is young males aged 16 to 17. This is the very same age range now approved by the FDA to receive mRNA injections from Pfizer-BioNTech.
Getting jabbed with these mRNA shots triples the risk of inflammatory heart tissue disease, and yet the FDA seems unconcerned about it – so much so that it no longer bothers to talk to its vaccine advisory committee.
Meanwhile, the U.S. Centers for Disease Control and Prevention (CDC) says that the survival rate from “covid” is still greater than 99.95 percent for people under the age of 50.
“As things stand, some 16,918 cases of myocarditis and pericarditis have been reported to the Vaccine Adverse Event Reporting System (VAERS), the joint FDA and CDC database for vaccine-related injury records,” reported LifeSiteNews.
“Despite the increasing reports of injuries, the FDA determined that ‘the benefits of a single booster dose of the Pfizer-BioNTech COVID-19 Vaccine or Comirnaty outweigh the risks of myocarditis and pericarditis in individuals 16 and 17 years of age to provide continued protection against COVID-19 and the associated serious consequences that can occur including hospitalization and death.'”
Almost immediately following the FDA’s latest authorization, CDC head Rochelle Walensky also signed off on injecting young teenagers with the shots.
“Today, the CDC is strengthening its booster recommendations and encouraging everyone 16 and older to receive a booster shot,” Walensky said in a pre-packaged statement that came just hours after the FDA’s announcement.
“I strongly encourage adolescents aged 16 and 17 to get their booster if they are at least 6 months post their initial Pfizer vaccination series,” she added, justifying this approval with claims that the all-new Moronic (Omicron) variant poses a potential threat to young people.
Neither the FDA nor the CDC consulted their respective advisory committees, it is important to once again emphasize. All of this is being done on the fly and at the discretionary whim of Walensky and other unelected globalists running “public health” here in the United States.
More of the latest news about Fauci Flu shots can be found at Genocide.news.
Sources for this article include:
Tagged Under: advisory committees, approval, Big Pharma, CDC, conspiracy, COVID, deception, FDA, pharmaceutical fraud, Plandemic, traitors, vaccine damage, vaccine injury, vaccines
COPYRIGHT © 2017 BIG PHARMA NEWS